高级检索
当前位置: 首页 > 详情页

The Effects of Different Calcium Channel Blockers on Aldosterone-Producing Adenoma Cells

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Chinese Acad Med Sci, Natl Hlth Commiss Peoples Republ China, Peking Union Med Coll Hosp, Dept Endocrinol,Key Lab Endocrinol,Peking Union M, Beijing, Peoples R China [2]Huazhong Univ Sci Technol, Dept Endocrinol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China [3]Chinese Acad Med Sci, Dept Urol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing, Peoples R China
出处:
ISSN:

关键词: aldosterone-producing adenoma calcium channel blocker ACTH angiotensin II benidipine

摘要:
Purpose: The aim of this study is to examine the effects of different kinds of calcium channel blockers (CCBs) on primary aldosterone-producing adenoma (APA) mainly with KCNJ5 mutations. Primary cultured APA cells were treated with different calcium channel blockers (L/T type CCB benidipine, T-type CCB mibefradil and L-type CCB nifedipine), and aldosterone secretagogues with or without nifedipine. Aldosterone level, aldosterone synthase (CYP11B2) mRNA expression and cell proliferation were detected. The results showed that all three CCBs significantly inhibit aldosterone secretion and CYP11B2 mRNA expression. Benidipine was relatively more effective than mibefradil or nifedipine. In addition, only mibefradil marginally inhibited cell proliferation. Adrenocorticotropin (ACTH) had a much stronger effect in stimulating aldosterone secretion and promoting cell proliferation from APA's than angiotensin II (ATII). Different from ACTH and ATII, potassium had no effect. Nifedipine inhibited the basal and ACTH-, ATII-elicited aldosterone secretion. Twenty three of 24 APAs had somatic KCNJ5 mutation. In conclusion, benidipine, mibefradil and nifedipine significantly inhibit aldosterone secretion in primary cultured APA cells.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 2 区 医学
小类 | 3 区 内分泌学与代谢
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢
JCR分区:
出版当年[2018]版:
Q2 ENDOCRINOLOGY & METABOLISM
最新[2023]版:
Q2 ENDOCRINOLOGY & METABOLISM

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者单位: [1]Chinese Acad Med Sci, Natl Hlth Commiss Peoples Republ China, Peking Union Med Coll Hosp, Dept Endocrinol,Key Lab Endocrinol,Peking Union M, Beijing, Peoples R China [2]Huazhong Univ Sci Technol, Dept Endocrinol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:428 今日访问量:2 总访问量:412 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)